Answers are grounded in this paper and cite their sources.
RNA sequencing (RNA-seq) is a valuable tool for variant interpretation and diagnosis of rare Mendelian disorders. However, the inability of standard short-read (SR) sequencing to resolve complex transcriptional changes restricts its full diagnostic potential. Long-read (LR) sequencing technologies overcome these constraints by sequencing full-length cDNA, though their diagnostic efficiency remains to be assessed. We performed LR RNA-seq using the PacBio Kinnex method in clinically accessible sample types (whole blood, fibroblasts, and lymphoblastoid cell lines (LCLs)) from 50 individuals with paired SR RNA-seq, including a n = 24 “control cohort”, previously diagnosed individuals with pathogenic mRNA aberrations, and a n = 26 “discovery cohort”, undiagnosed individuals with candidate DNA variants suitable for interrogation by RNA-seq. We generate reference data sets, perform key bench-marking analyses and develop a novel bioinformatics and analytical pipeline to capture pathogenic transcriptional changes, including splicing changes, gene expression changes, differential isoform usage, allelic biases, gene fusions, and structural variants. We go on to find that LR RNA-seq results in a streamlined analysis output and that it provides improved resolution and mechanistic insights compared with SR RNA-seq in over half of our cases with positive RNA findings (57% control cohort, 80% discovery cohort). We identify key advantages of the isoform-level resolution provided by LR RNA-seq including direct phasing of variant consequences, clarification of splice junction boundaries, differential isoform usage analysis, identification of novel transcriptional events, and characterization of the consequences of structural variants and gene fusions. A highlight of these findings includes the first report of autosomal recessive Cleidocranial Dysplasia. Despite many advantages, we also identify and highlight critical limitations of LR RNA-seq including poor capture of short isoforms and uneven coverage in specific long transcripts. Altogether, we find that LR RNA-seq streamlines transcriptome analysis in complex scenarios. Our study provides important insights into the clinical application of this novel technology.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: